ANIMAL BIOTECH INDUSTRIES INC

ANIMAL BIOTECH INDUSTRIES INC specializes in biotechnological research and development services supporting federal science and health initiatives, with a focus on animal health, veterinary diagnostics, and life sciences innovation. Their core capabilities include the design and validation of diagnostic assays, biosafety-compliant laboratory operations, and the development of proprietary bioassay platforms for pathogen detection and vaccine efficacy evaluation. The company leverages advanced molecular biology techniques such as PCR, ELISA, and next-generation sequencing to deliver high-integrity data packages for regulatory submissions. Key differentiators include their proprietary sample processing protocols and experience navigating USDA and FDA regulatory pathways for veterinary biologics and in vitro diagnostic devices. Their work emphasizes reproducibility, biosafety level compliance, and data integrity standards critical to federal research programs. Award history is not available to confirm specific agency engagements, but their technical profile suggests alignment with USDA, NIH, CDC, and DOD agencies engaged in zoonotic disease surveillance, animal model development, and agricultural biosecurity. Their expertise in veterinary biotechnology positions them to support mission-critical programs related to food safety, emerging pathogens, and one health initiatives. The company operates within the life sciences and biomedical research vertical, primarily serving NAICS 424520 — Wholesale Trade of Medical and Dental Equipment and Supplies — which, in practice, reflects their role in supplying specialized biotech reagents, diagnostic kits, and research tools to government laboratories and contracted research entities. Their market positioning centers on bridging commercial biotech innovation with federal research requirements. ANIMAL BIOTECH INDUSTRIES INC is a woman-owned business headquartered in Doylestown, Pennsylvania, with a lean, specialized operational structure designed for agile R&D execution. The company holds formal certification as a Woman-Owned Business under the SBA’s Women-Owned Small Business Program, enhancing its eligibility for targeted federal set-asides. Their geographic presence is concentrated in the Mid-Atlantic region, with operations calibrated to support federal research hubs and biosafety infrastructure networks.